Gold Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Gold Investment Management's PFE Position: Q1 2026 in Review
Gold Investment Management increased its Pfizer (PFE) stake by 1.9% in Q1 2026, buying an estimated $28.6K and bringing the position to 56,466 shares worth $1.59M. The position accounts for 0.49% of the portfolio, ranked #66.
Gold Investment Management first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Gold Investment Management held 56,466 shares of Pfizer worth $1.59M as of Q1 2026.
- Gold Investment Management bought 1,074 Pfizer shares in Q1 2026, an estimated $28.6K.
- Pfizer made up 0.49% of Gold Investment Management's portfolio in Q1 2026, its #66 holding.
- Gold Investment Management first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Gold Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.